Literature DB >> 33815709

Upgrading treatment strategies of cardiovascular diseases using biotechnology: Are we still there?

Sara Pahlavan1, Sahand Abrishami2.   

Abstract

Entities:  

Year:  2021        PMID： 33815709      PMCID： PMC8007892          DOI： 10.34172/jcvtr.2021.19

Source DB:  PubMed          Journal:  J Cardiovasc Thorac Res        ISSN： 2008-5117


× No keyword cloud information.
  6 in total

Review 1.  Cell therapy trials for heart regeneration - lessons learned and future directions.

Authors:  Philippe Menasché
Journal:  Nat Rev Cardiol       Date:  2018-11       Impact factor: 32.419

Review 2.  Gene Therapy for the Heart Lessons Learned and Future Perspectives.

Authors:  Antonio Cannatà; Hashim Ali; Gianfranco Sinagra; Mauro Giacca
Journal:  Circ Res       Date:  2020-05-07       Impact factor: 17.367

Review 3.  Is Cardioprotection Dead?

Authors:  David J Lefer; Eduardo Marbán
Journal:  Circulation       Date:  2017-07-04       Impact factor: 29.690

Review 4.  Cardiomyocyte Regeneration: A Consensus Statement.

Authors:  Thomas Eschenhagen; Roberto Bolli; Thomas Braun; Loren J Field; Bernd K Fleischmann; Jonas Frisén; Mauro Giacca; Joshua M Hare; Steven Houser; Richard T Lee; Eduardo Marbán; James F Martin; Jeffery D Molkentin; Charles E Murry; Paul R Riley; Pilar Ruiz-Lozano; Hesham A Sadek; Mark A Sussman; Joseph A Hill
Journal:  Circulation       Date:  2017-07-06       Impact factor: 29.690

Review 5.  Modified mRNA as a Therapeutic Tool for the Heart.

Authors:  Keerat Kaur; Lior Zangi
Journal:  Cardiovasc Drugs Ther       Date:  2020-08-21       Impact factor: 3.727

Review 6.  Cardiac progenitor cells application in cardiovascular disease.

Authors:  Hassan Amini; Jafar Rezaie; Armin Vosoughi; Reza Rahbarghazi; Mohammad Nouri
Journal:  J Cardiovasc Thorac Res       Date:  2017-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.